Larvol Delta - Aperture-Therapeutics-Announces-Development-Candidate-Targeting-CD33-to-Restore-Microglial-Homeostasis-in-FTD-and-ALS

APRTX-001 - Aperture Therapeutics

https://www.lelezard.com/en/news-22024431.html

Nov 19, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev